General News

On World Brain Tumor Day, we join the global community in raising awareness of brain tumors and honoring the patients, families, clinicians, and researchers working toward better outcomes every day.

Brain tumors remain one of health-care’s most complex challenges, where timely diagnosis and informed clinical decision can make a meaningful difference. Molecular biomarkers such as BRAF V600E can provide important insights into certain brain tumor types, helping support more personalized treatment strategies and patient management.

As molecular diagnostics continue to advance, they are enabling healthcare professionals to gain deeper insights and support more precise answers when they matter most.

This World Brain Tumor Day, we stand with everyone affected by brain tumors and reaffirm our commitment to advancing diagnostics innovation for a healthier future.